Lorlatinib Versus Pemetrexed-Based Chemotherapy in Patients With ALK-rearranged NSCLC Previously Treated With Alectinib by Takeyasu, Yuki, MD, Yoshida, Tatsuya, XX, Masuda, Ken, XX, Matsumoto, Yuji, XX, Shinno, Yuki, XX, Okuma, Yusuke, XX, Goto, Yasushi, XX, Horinouchi, Hidehito, XX, Yamamoto, Noboru, XX, Ohe, Yuichiro, XX

Get full text

Creation of an Integrated Clinical Trial Database and Data Sharing for Conducting New Research by the Japanese Lung Cancer Society by Ozawa, Yuichi, MD, PhD, Yamamoto, Nobuyuki, XX, Yamamoto, Kouji, XX, Ito, Kentaro, XX, Kenmotsu, Hirotsugu, XX, Hayashi, Hidetoshi, XX, Shukuya, Takehito, XX, Fujimoto, Daichi, XX, Sugawara, Shunichi, XX, Niho, Seiji, XX, Ohe, Yuichiro, XX, Okamoto, Hiroaki, XX, Nakagawa, Kazuhiko, XX, Kiura, Katsuyuki, XX, Yoshino, Ichiro, XX, Gemma, Akihiko, XX

Get full text

Immunologic Significance of CD80/CD86 or Major Histocompatibility Complex-II Expression in Thymic Epithelial Tumors by Ikeda, Hideki, MD, Nagasaki, Joji, MD, PhD, Shimizu, Daiki, MD, Katsuya, Yuki, MD, PhD, Horinouchi, Hidehito, MD, PhD, Hosomi, Yukio, MD, PhD, Tanji, Etsuko, XX, Iwata, Takekazu, MD, PhD, Itami, Makiko, MD, PhD, Kawazu, Masahito, MD, PhD, Ohe, Yuichiro, MD, PhD, Suzuki, Takuji, MD, PhD, Togashi, Yosuke, MD, PhD

Get full text

Phase 2 Study of YS110, a Recombinant Humanized Anti-CD26 Monoclonal Antibody, in Japanese Patients With Advanced Malignant Pleural Mesothelioma by Nakagawa, Kazuhiko, MD, PhD, Kijima, Takashi, MD, PhD, Okada, Morihito, MD, PhD, Morise, Masahiro, MD, PhD, Kato, Motoyasu, MD, PhD, Hirano, Katsuya, MD, Fujimoto, Nobukazu, MD, PhD, Takenoyama, Mitsuhiro, MD, PhD, Yokouchi, Hiroshi, MD, PhD, Ohe, Yuichiro, MD, Hida, Toyoaki, MD, PhD, Aoe, Keisuke, MD, PhD, Kishimoto, Takumi, MD, PhD, Hirokawa, Masato, XX, Matsuki, Hironori, XX, Kaneko, Yutaro, XX, Yamada, Taketo, MD, PhD, Morimoto, Chikao, MD, PhD, Takeda, Masayuki, MD, PhD

Get full text